Cargando...
Gene Therapy For Beta-Thalassemia: Updated Perspectives
Allogeneic hematopoietic stem cell transplantation was until very recently, the only permanent curative option available for patients suffering from transfusion-dependent beta-thalassemia. Gene therapy, by autologous transplantation of genetically modified hematopoietic stem cells, currently represe...
Guardado en:
| Publicado en: | Appl Clin Genet |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6765258/ https://ncbi.nlm.nih.gov/pubmed/31576160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TACG.S178546 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|